NCT07365878

Brief Summary

The aim of the study is to determine the effect Dry Needling of on insulin resistance in obese postmenopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

December 14, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

December 14, 2025

Last Update Submit

January 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • HOMA-IR

    Outcome measures, HOMA-IR (Homeostasis Model Assessment) will be used to assess insulin resistance. HOMA-IR is a model of interactions between glucose and insulin dynamics that is then used to predict fasting steady-state glucose and insulin concentrations for a wide range of possible combinations of insulin resistance and β-cell function.

    4 months

Secondary Outcomes (4)

  • ultrasound

    4 months

  • BMI by kg/m2

    4 months

  • waist circumferences by tape

    4 months

  • The surface under the cumulative ranking curve (SUCRA)

    4 months

Study Arms (2)

Dry Needle

EXPERIMENTAL

26 patients who were treated with Dry Needling (three times /week/4 months), abdominal exercises, and medical standard care for insulin resistance.

Other: Dry NeedleOther: abdominal exercises, and medical standard care for insulin resistance

abdominal exercises and medical standard care for insulin resistance.

OTHER

While Group (B), 26 patients treated with abdominal exercises and medical standard care for insulin resistance.

Other: abdominal exercises, and medical standard care for insulin resistance

Interventions

Dry Needle has been used to treat obesity. Clinical research has found that it is particularly effective for abdominal fat loss.Dry needling in the abdominal region requires an in-depth understanding of the underlying anatomy due to significant safety risks.

Dry Needle

To reduce belly fat, combine core-strengthening exercises like planks, bicycle crunches, and leg raises with overall fat-burning cardio (walking, running) and a healthy diet

Dry Needleabdominal exercises and medical standard care for insulin resistance.

Eligibility Criteria

Age48 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All participants post-menopausal from at least 3 years.
  • All participants' ages will be ranged from 48-60 years old.
  • All participants BMI will exceed 25-30 kg/m2.
  • All participants waist hip ratio will be equal or more than 0, 90.

You may not qualify if:

  • Surgical liposuction within the last 12 months.
  • Untreated hypo- or hyperthyroidism.
  • Uncontrolled liver, kidney or cardiovascular disease or diabetes.
  • Implanted pacemaker or metal implant.
  • History of thrombophlebitis, any hematological disease.
  • No past or present neurological and musculoskeletal disorders that will have affected health condition.
  • No smoking and drinking habits.
  • No psychological problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shymaa Mohammed

Cairo, Egypt

Location

Study Officials

  • Shymaa Mohammed

    out patient clinic ,faculty of physical therapy ,Cairo university ,Cairo,Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

December 14, 2025

First Posted

January 26, 2026

Study Start

January 1, 2025

Primary Completion

April 1, 2025

Study Completion

December 1, 2025

Last Updated

January 26, 2026

Record last verified: 2026-01

Locations